ArticleSurgery open science2026
Utilization of whole-body computed tomography in trauma: The role of trauma center level and ACS verification.
Article in Surgery open science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Whole-body computed tomography (WBCT) is frequently used in trauma, though its value in stable patients remains uncertain. We examined WBCT use after motor vehicle collision (MVC) and whether trauma center designation and American College of Surgeons Committee on Trauma (ACS-COT) verification were associated with imaging practices. Methods: Using 2018-2021 Trauma Quality Improvement Program (TQIP) data, we identified adults aged 18-65 with blunt MVC who were stable (systolic blood pressure ≥ 100 and Glasgow Coma Scale 15) and received a CT scan. WBCT was defined as head, chest, and abdomen CT within 2 h of admission; selective CT (SCT) covered fewer than all three regions. Temporal trends by state-designated trauma level and ACS-COT verification were assessed using Cuzick's nonparametric test, and multivariable logistic regression identified factors associated with WBCT use. Results: Among 288,264 stable MVC patients receiving CT, 78,796 (27.3%) underwent WBCT, and 209,468 (72.7%) SCT. WBCT utilization declined at ACS-verified (31.9 to 30.2%) and non-verified centers (22.0 to 18.4%), and at Level I (29.1 to 27.1%) and Level II (28.5 to 26.9%) facilities (all nptrend <0.001), with consistent declines across Injury Severity Score strata. After adjustment, ACS verification was associated with higher odds of WBCT (AOR 1.96, 95% CI 1.92-2.00), whereas non-profit or government ownership (AOR 0.55, 95% CI 0.54-0.57) was associated with lower odds. Conclusions: In stable MVC patients, WBCT utilization declined from 2018 to 2021 across trauma levels and verification strata, while institutional characteristics remained strongly associated with WBCT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.